logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
A

Ana Arance

University of Barcelona
H指数:64
被引数:3.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Relatlimab plus nivolumab versus nivolumab for advanced melanoma: 5-year survival and biomarker analyses of the phase 3 RELATIVITY-047 trial

瑞利替尼单抗联合纳武利尤单抗对比纳武利尤单抗治疗晚期黑色素瘤：RELATIVITY-047 III期试验5年生存率及生物标志物分析

Nature Medicine
IF50
2026-10-240
OAAI
Georgina V. Long; Sonia Dolfi; F. Stephen Hodi; Evan J. Lipson; Dirk Schadendorf; Paolo A. Ascierto; Luis Matamala; Erika Castillo Gutiérrez; Piotr Rutkowski; Helen J. Gogas; Leslie A. Fecher; Christopher D. Lao; Juliana Janoski De Menezes; Stéphane Dalle; Ana Arance; Caroline Gaudy-Marqueste; Emilio Murillo; Michele Maio; Maximilian Rohde; Charlie Garnett-Benson; Ruiyun Jiang; Bohang Chen; Jia Xin Yu; Travis Hollmann; Gabriele Zuchtriegel; Hussein Tawbi
Assessing brain metastasis response to immunotherapy: a pictorial review of atypical responses and intracranial adverse events

评估脑转移瘤对免疫治疗的反应：不典型反应和颅内不良事件的影像学综述

Insights into Imaging
IF4.5
2025-11-190
OAAI
Gary Amseian; Francisco Aya; Camilo Pineda; Sofía González-Ortiz; Juan-Andrés Mora; Maria-Lourdes Olondo; Andres Perissinotti; Gabriela-Ailen Caballero; Iban Aldecoa; Laura Mezquita; Josep Puig; Ana Arance; Núria Bargalló; Laura Oleaga
Nivolumab for Resected Stage III or IV Melanoma at 9 Years

纳武利尤单抗治疗已切除III期或IV期黑色素瘤9年结果

NEW ENGLAND JOURNAL OF MEDICINE
IF78.5
2025-10-015
PRE
Ascierto, Paolo A.; Del Vecchio, Michele; Merelli, Barbara; Gogas, Helen; Arance, Ana M.; Dalle, Stephane; Cowey, Charles Lance; Schenker, Michael; Gaudy-Marqueste, Caroline; Pigozzo, Jacopo; Marquez-Rodas, Ivan; Butler, Marcus O.; Di Giacomo, Anna Maria; Gligich, Oleg; de la Cruz-merino, Luis; Arenberger, Petr; Atkinson, Victoria; Nathan, Paul; Hill, Andrew; Millward, Michael; Fecher, Leslie A.; Khushalani, Nikhil I.; Queirolo, Paola; Soomro, Raheela; Rathod, Dhanrajsinh; Askelson, Margarita; Pe Benito, Melanie; Joseph, Devanand; Larkin, James
Efficacy of anti-PD1 therapy in PD1-high mRNA tumors across multiple cancer types: results from cohort 1 and cohort 2 of the phase II SOLTI-1904 ACROPOLI trial

PD1疗法在PD1高表达mRNA肿瘤中的疗效：SOLTI-1904 ACROPOLI II期试验中队列1和队列2的结果

ESMO Open
IF8.3
2025-09-300
OAAI
E. Seguí; F. Brasó-Maristany; T. Pascual; E. Sanfeliu; I. Victoria; C. Saura; C. Hierro; A. López-González; Y. Izarzugaza; E. Ciruelos; J. Gavilá; F. Racca; J.M. Cejalvo; K. Amillano; L. Paz-Ares; M. Juan; E. Felip; E. Garralda; B. González; A. Arance; J. Martín-Liberal; B. Conte; B. Walbaum; A. Indacochea; O. Castillo; P. Blasco; F. Pardo; Á. Aguirre; V. Sirenko; X. González; P. Galván; A. Vivancos; J.M. Ferrero-Cafiero; A. Mulero-Sánchez; F. Salvador; G. Villacampa; R. Mesía; A. Cervantes; A. Prat; J. Tabernero
Randomized, Double-Blind, Phase III LEAP-003 Study of First-Line Lenvatinib Plus Pembrolizumab Versus Placebo Plus Pembrolizumab for Unresectable or Metastatic Melanoma

随机、双盲、III期LEAP-003研究：比较一线仑伐替尼联合帕博利珠单抗与安慰剂联合帕博利珠单抗治疗不可切除或转移性黑色素瘤的疗效。

Annals of Oncology
IF65.4
2025-08-280
PREAI
A. Arance; M.-A. Berciano-Guerrero; J. Guo; M.S. Carlino; P.A. Ascierto; M. Burotto; L. Mortier; P. Queirolo; V. Chiarion-Sileni; J. Schachter; X. Zhang; J. Martin-Liberal; M. Del Vecchio; C.E. Okpara; C. Dutcus; J. Zhang; S.J. Diede; T. Neff; G.V. Long
Combined immunotherapy with nivolumab and ipilimumab with and without sequential or concomitant stereotactic radiotherapy in patients with melanoma brain metastasis: An international retrospective study

联合使用纳武利尤单抗和伊匹木单抗的免疫治疗，以及联合或不联合序贯或同步立体定向放射治疗在黑色素瘤脑转移患者中的应用：一项国际回顾性研究

European Journal of Cancer
IF7.1
2025-06-090
OA
Mario Mandalà; Teresa Amaral; Piotr Rutkowski; Maria Chiara Sergi; Marie-Lena Rasch; Naima Benannoune; Patricio Serra; Maria Grazia Vitale; Diana Giannarelli; Ana Maria Arance; Eva Munoz Couselo; Bart Neyns; Iris Dirven; Marco Tucci; Michele Guida; Francesco Spagnolo; Ernesto Rossi; Paola Queirolo; Pietro Quaglino; Roberta Depenni; Paolo A. Ascierto
Combination of encorafenib and binimetinib followed by ipilimumab and nivolumab versus ipilimumab and nivolumab in patients with advanced melanoma with BRAFV600E or BRAFV600K mutations (EBIN): an international, open-label, randomised, controlled, phase 2 study

联合使用encorafenib和binimetinib，随后使用ipilimumab和nivolumab，与直接使用ipilimumab和nivolumab相比，在携带BRAFV600E或BRAFV600K突变的晚期黑色素瘤患者中的疗效比较（EBIN）：一项国际、开放标签、随机对照、二期研究

lancet oncology
IF0
2025-05-280
PRE
Caroline Robert; Michal Kicinski; Caroline Dutriaux; Émilie Routier; Anne-Sophie Govaerts; Emanuel Bührer; Eve-Marie Neidhardt; Xavier Durando; Barouyr Baroudjian; Philippe Saiag; Caroline Gaudy-Marqueste; Paolo A Ascierto; Ana Arance; Michelangelo Russillo; Jean-Luc Perrot; Laurent Mortier; Francois Aubin; Stéphane Dalle; Florent Grange; Eva Muñoz-Couselo; Alexander C J van Akkooi
An Open-label, Randomized Study of Melphalan/Hepatic Delivery System Versus Best Alternative Care in Patients with Unresectable Metastatic Uveal Melanoma

不可切除的转移性葡萄膜黑色素瘤患者美法仑/肝递送系统与最佳替代护理的开放标签，随机研究

ANNALS OF SURGICAL ONCOLOGY
IF3.5
2025-04-010
OAAI
Zager, Jonathan S.; Orloff, Marlana; Ferrucci, Pier Francesco; Choi, Junsung; Eschelman, David J.; Glazer, Evan S.; Ejaz, Aslam; Howard, J. Harrison; Richtig, Erika; Ochsenreither, Sebastian; Reddy, Sunil A.; Lowe, Michael C.; Beasley, Georgia M.; Gesierich, Anja; Bender, Armin; Gschnell, Martin; Dummer, Reinhard; Rivoire, Michel; Arance, Ana; Fenwick, Stephen William; Sacco, Joseph J.; Haferkamp, Sebastian; Weishaupt, Carsten; John, Johnny; Wheater, Matthew; Ottensmeier, Christian H.
Cutaneous melanoma: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

皮肤黑色素瘤：ESMO 临床实践指南（用于诊断、治疗和随访）

ANNALS OF ONCOLOGY
IF65.4
2025-01-0111
PRE
Amaral, T.; Ottaviano, M.; Arance, A.; Blank, C.; Chiarion-Sileni, V.; Donia, M.; Dummer, R.; Garbe, C.; Gershenwald, J. E.; Gogas, H.; Guckenberger, M.; Haanen, J.; Hamid, O.; Hauschild, A.; Hoeller, C.; Lebbe, C.; Lee, R. J.; Long, G., V; Lorigan, P.; Couselo, E. Munoz; Nathan, P.; Robert, C.; Romano, E.; Schadendorf, D.; Sondak, V; Suijkerbuijk, K. P. M.; van Akkooi, A. C. J.; Michelin, O.; Ascierto, P. A.
Nature and management of melanoma recurrences following adjuvant anti-PD-1 based therapy
EUROPEAN JOURNAL OF CANCER
IF7.1
2024-11-010
PRE
Woodford, Rachel; McKeown, Janet; Hoeijmakers, Lotte L.; Mangana, Johanna; Dimitriou, Florentia; Allayous, Clara; Zaman, Farzana; Aya, Francisco; Marsiglio, John; Goodman, Rachel; Rayson, Victoria; Placzke, Joanna; Kessels, Jolien; Ramalyte, Egle; Haque, Waqas; Wilson, Isabella; Trojaniello, Claudia; Benannoune, Naima; Roberts-Thomson, Rachel; Robert, Caroline; Blank, Christian U.; Dummer, Reinhard; Lebbe, Celeste; Haydon, Andrew; Arance, Ana; Hu-Lieskovan, Siwen; Johnson, Douglas B.; Mcarthur, Grant A.; Rutkowski, Piotr; Neyns, Bart; Sullivan, Ryan J.; Weber, Jeffrey; Carlino, Matteo S.; Ascierto, Paolo A.; Lo, Serigne; Long, Georgina, V; Menzies, Alexander M.
Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study
AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
IF8.8
2024-10-080
OAAI
Mortier, Laurent; Villabona, Lisa; Lawrence, Ben; Arance, Ana; Butler, Marcus O.; Beylot-Barry, Marie; Saiag, Philippe; Samimi, Mahtab; Ascierto, Paolo A.; Spada, Francesca; De Pontville, Michel; Maio, Michele; Berrocal, Alfonso; Espinosa, Enrique; Capdevila, Jaume; Levin, Max; Das, Debasmita; Krepler, Clemens; Grebennik, Dmitri; Chiarion-Sileni, Vanna
Subgroup analysis of FOCUS phase III trial efficacy results

FOCUS III期试验疗效结果的亚组分析

ANNALS OF ONCOLOGY
IF65.4
2024-09-010
PRE
Wheater, M.; Orloff, M.; Ferrucci, P. F.; Choi, J.; Eschelman, D.; Glazer, E.; Ejaz, A.; Richtig, E.; Ochsenreither, S.; Reddy, S. A.; Lowe, M.; Beasley, G.; Gesierich, A.; Gschnell, M.; Dummer, R.; Arance, A. M.; Fenwick, S.; John, J.; Ottensmeier, C. H. H.; Zager, J. S.
Type II RAF inhibitor tovorafenib in recurrent/refractory (R/R) melanoma or other solid tumors with RAF fusions and/or RAF1 amplification

Type II RAF抑制剂tovorafenib在复发/难治性（R/R）黑色素瘤或其他具有RAF融合和/或RAF1扩增的实体瘤中的应用

ANNALS OF ONCOLOGY
IF65.4
2024-09-011
PRE
Vieito, M.; Garralda, E.; Mehmi, I.; Marqueste, C. Gaudy; O'Neil, B. H.; Medina, T. M.; Body, A.; Arance, A. M.; Kummar, S.; Najjar, Y. G.; Bedard, P. L.; Chu, C.; McKenna, C.; Hume, S.; Kopp, L. M.; Lee, J.
Efficacy and Safety of the Melphalan/Hepatic Delivery System in Patients with Unresectable Metastatic Uveal Melanoma: Results from an Open-Label, Single-Arm, Multicenter Phase 3 Study (vol 31, pg 5340, 2024)
ANNALS OF SURGICAL ONCOLOGY
IF3.5
2024-07-180
OAAI
Zager, Jonathan S.; Orloff, Marlana; Ferrucci, Pier Francesco; Choi, Junsung; Eschelman, David J.; Glazer, Evan S.; Ejaz, Aslam; Howard, J. Harrison; Richtig, Erika; Ochsenreither, Sebastian; Reddy, Sunil A.; Lowe, Michael C.; Beasley, Georgia M.; Gesierich, Anja; Bender, Armin; Gschnell, Martin; Dummer, Reinhard; Rivoire, Michel; Arance, Ana; Fenwick, Stephen William; Sacco, Joseph J.; Haferkamp, Sebastian; Weishaupt, Carsten; John, Johnny; Wheater, Matthew; Ottensmeier, Christian H.
Operational classification of cutaneous squamous cell carcinomas based on unsupervised clustering of real cases by experts
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
IF8
2024-07-030
OAAI
Gaudy-Marqueste, C.; Grob, J. J.; Garbe, C.; Ascierto, P. A.; Arron, S.; Basset-Seguin, N.; Bohne, A. S.; Lenoir, C.; Dummer, R.; Fargnoli, M. C.; Guminski, A.; Hauschild, A.; Kaufmann, R.; Lallas, A.; del Marmol, V.; Migden, M.; Penicaud, M.; Rembielak, A.; Stratigos, A.; Tagliaferri, L.; Zalaudek, I.; Arance, A.; Badinand, D.; Bossi, P.; Challapalli, A.; Clementi, M.; Di Stefani, A.; Ferrandiz-Pulido, C.; Giuffrida, R.; Gravina, G. L.; Ha, P.; Heinzerling, L.; Mallet, S.; Paradisi, A.; Mohr, P.; Piccerillo, A.; Rutkowski, D.; Saiag, P.; Sollena, P.; Trakatelli, M.; Wojcieszek, P.; Yom, S. S.; Zelin, E.; Peris, K.; Malvehy, J.
Encorafenib and binimetinib followed by radiotherapy for patients with BRAFV600-mutant melanoma and brain metastases (E-BRAIN/GEM1802 phase II study)

恩科非尼和比尼美替尼联合放疗治疗BRAFV600-mutant黑色素瘤和脑转移患者 (e-brain/GEM1802 II期研究)

NEURO-ONCOLOGY
IF13.4
2024-07-010
OAAI
Marquez-Rodas, Ivan; Alvarez, Ana; Arance, Ana; Valduvieco, Izaskun; Berciano-Guerrero, Miguel-angel; Delgado, Raquel; Soria, Ainara; Campos, Fernando Lopez; Sanchez, Pedro; Romero, Jose Luis; Martin-Liberal, Juan; Lucas, Anna; Diaz-Beveridge, Roberto; Conde-Moreno, Antonio-Jose; de la Gala, Maria del Carmen Alamo; Garcia-Castano, Almudena; Prada, Pedro Jose; Cao, Maria Gonzalez; Puertas, Enrique; Vidal, Joana; Foro, Palmira; de la Rosa, Carlos Aguado; Corona, Juan Antonio; Cerezuela-Fuentes, Pablo; Lopez, Paco; Luna, Pablo; Aymar, Neus; Puertolas, Teresa; Sanagustin, Pilar; Berrocal, Alfonso
Anti-PD-1 alone or in combination with anti-CTLA-4 for advanced melanoma patients with liver metastases

单独Anti-PD-1或联合anti-CTLA-4治疗晚期黑色素瘤肝转移患者

EUROPEAN JOURNAL OF CANCER
IF7.1
2024-07-011
PRE
da Silva, Ines Pires; Li, Isabel; Ugurel, Selma; Serra-Bellver, Patricio; Andhale, Avanti; Burnette, Hannah; Aya, Francisco; Conway, Jordan W.; Braden, Jorja; Carlino, Matteo S.; Menzies, Alexander M.; Weichenthal, Michael; Mohr, Peter; Gutzmer, Ralf; Arance, Ana M.; Johnson, Douglas B.; Lorigan, Paul; Schadendorf, Dirk; Lo, Serigne N.; Long, Georgina V.

研究方向

Translational genomics and targeted therapies in s
P
Paolo A. Ascierto
H 指数:126论文数:1,662被引数:10.8万
G
Georgina V. Long
H 指数:169论文数:1,833被引数:17.2万
C
Caroline Robert
H 指数:154论文数:1,485被引数:15.7万
M
Mario Mandalà
H 指数:78论文数:519被引数:3.9万
H
Helen Gogas
H 指数:74论文数:603被引数:3.4万
D
Dirk Schadendorf
H 指数:182论文数:2,386被引数:22.1万
J
Jean‐Jacques Grob
H 指数:107论文数:1,027被引数:8.1万
J
James Larkin
H 指数:128论文数:1,339被引数:13.2万
P
Paul Lorigan
H 指数:87论文数:684被引数:6.3万
R
Reinhard Dummer
H 指数:152论文数:2,780被引数:12.7万